tiprankstipranks
CytoMed Therapeutics Limited (GDTC)
NASDAQ:GDTC
US Market
GDTC
CytoMed Therapeutics Limited
RESEARCH TOOLSreports

CytoMed Therapeutics Limited (GDTC) Stock News & Sentiment

23 Followers
CytoMed Therapeutics Widens 2025 Loss as It Accelerates Cell Therapy Trials and Southeast Asia Expansion
Premium
Company Announcements
CytoMed Therapeutics Widens 2025 Loss as It Accelerates Cell Therapy Trials and Southeast Asia Expansion
13d ago
6K
GDTC
CytoMed Therapeutics Refutes Misleading Claims, Confirms Ongoing First-in-Human Trial
Premium
Company Announcements
CytoMed Therapeutics Refutes Misleading Claims, Confirms Ongoing First-in-Human Trial
3M ago
6K
GDTC
CytoMed Therapeutics Outlines 2026 Clinical Plans and Seeks Shareholder Input on Patient-Access Scheme
Premium
Company Announcements
CytoMed Therapeutics Outlines 2026 Clinical Plans and Seeks Shareholder Input on Patient-Access Scheme
3M ago
6K
GDTC
CytoMed Therapeutics Partners with Malaysian Hospital for Groundbreaking Cancer Trial
Premium
Company Announcements
CytoMed Therapeutics Partners with Malaysian Hospital for Groundbreaking Cancer Trial
4M ago
6K
GDTC
CytoMed Therapeutics Finalizes Acquisition of T Cell Technology for Cancer Treatment in China and India
Premium
Company Announcements
CytoMed Therapeutics Finalizes Acquisition of T Cell Technology for Cancer Treatment in China and India
5M ago
6K
GDTC
CytoMed Therapeutics Secures Investment and Advances China Strategy
Premium
Company Announcements
CytoMed Therapeutics Secures Investment and Advances China Strategy
5M ago
6K
GDTC
CytoMed Therapeutics’ ANGELICA Trial: A New Frontier in Cancer Treatment
Premium
Company Announcements
CytoMed Therapeutics’ ANGELICA Trial: A New Frontier in Cancer Treatment
6M ago
GDTC
More GDTC News >

GDTC News on the Web

CytoMed Therapeutics Widens 2025 Loss as It Accelerates Cell Therapy Trials and Southeast Asia Expansion
TipRanks News
Bearish
CytoMed Therapeutics Refutes Misleading Claims, Confirms Ongoing First-in-Human Trial
TipRanks News
Bearish
Cytomed Therapeutics refutes ‘misleading’ claims, reaffirms clinical progress
TipRanks News
Neutral
CytoMed Therapeutics Outlines 2026 Clinical Plans and Seeks Shareholder Input on Patient-Access Scheme
TipRanks News
Bearish
Cytomed sees ‘enough resources’ to continue activites for ‘at least a year’
TipRanks News
Bullish
CytoMed Therapeutics Schedules AGM for June 2025
TipRanks News
Neutral
CytoMed Therapeutics Reports 2024 Financial Results and Clinical Progress
TipRanks News
Neutral
CytoMed Therapeutics and SunAct to conduct solid tumour treatment trial in India
Clinical Trials Arena
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GDTC’s Media Buzz Sentiment?
Currently, no data Available
What is GDTC’s weekly average amount of articles?
Currently, no data Available
What is GDTC’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
AORTArtivion
STAAStaar Surgical
IVVDInvivyd
SLPSimulations Plus
REPLReplimune Group
Showing the stocks with the most bullish news sentiment over the past week